Skip to main content
. Author manuscript; available in PMC: 2019 Jan 12.
Published in final edited form as: ACS Infect Dis. 2017 Sep 20;4(1):39–45. doi: 10.1021/acsinfecdis.7b00114

Figure 3.

Figure 3

Characterization of MccH47-based inhibition of E. coli DH5α by EcN pttrMcH47, with EcN pBR322 control, as a function of 0.2 mM 2,2′-dipyridyl (D), 0.1% D-Glucose (G), and 1 mM of potassium tetrathionate (T). + stands for compound present; – stands for compound absent.

HHS Vulnerability Disclosure